Bottle Label 800 mg (71610 0778 53)
Gabapentin Tablet
Product Images NDC 71610-778
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71610-778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure 1 (Image 01)
Figure 2 (Image 02)
This text appears to be a chart or graph displaying the results of a study or experiment. It shows the dosage of a medication called Gabapentin over a 4-week period. There are three groups: one receiving a placebo, one receiving 1800 mg/day of Gabapentin, and one receiving 2400 mg/day of Gabapentin. The graph also displays the mean pain score over the course of the study, with baseline and weeks 1-7 marked. Overall, it seems to be evaluating the effectiveness of different doses of Gabapentin in reducing pain.*
Figure 3 (Image 03)
Image-04 (Image 04)
Gabapentin Structural Formula (Image 05)
Image-09 (Image 09)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
